Dr. Wu is a pediatric and clinical child psychologist, assistant professor of dermatology, and a member of the Cancer Control and Population Sciences Program at Huntsman Cancer Institute. Dr. Wu...
One of the most significant obstacles cancer patients face is resistance to drug treatment. Aggressive tumors often become adept at resisting the powerful drugs used to combat them. Therapeutic agents...
Utah has the highest rate of melanoma in the United States. Melanoma is an aggressive skin cancer that spreads quickly. Allie Grossmann, MD, PhD, focuses on identifying better ways to...
Last week, Sigma Chi International Fraternity announced a new $20-million pledge to Huntsman Cancer Foundation, dedicated to and used for women’s cancer research, treatment and wellness at Huntsman Cancer Institute.
When Ryan Smith's father was diagnosed with cancer, the two of them decided to dedicate themselves to cancer. They committed that if they ever made any more money or had...
A study by KT Varley, PhD, aims to improve treatments for triple-negative breast cancer patients. Findings could be used to determine who could safely be treated with less aggressive therapy.
Pancreatic cancer is relatively rare, but chances are likely you care for several patients with a family member who has been diagnosed with pancreatic cancer. New data insights outline pancreas...
Scientists at Huntsman Cancer Institute work hard every day to understand cancer from its beginnings and to use that knowledge in the creation and improvement of cancer treatments. To recognize...
Brad Cairns, PhD, focuses on determining, at the mechanistic level, how a cell normally regulates processes important to cancer. He is not only a scientist, he also loves mountain biking...
Do you ever wonder how cancer statistics are collected? How doctors determine what cancer treatments are the most effective? Or how public health officials learn where clusters of cancer diagnoses...
Huntsman Cancer Institute contributed to two research studies involving how microbes living in and on our body play a role in the development of colorectal cancer.
We can only imagine how hard it must be for patients, along with their caregivers and loved ones, to hear they have cancer. Our shared purpose is to make it...
Huntsman Cancer Institute's CEO, Mary Beckerle, PhD, and Senior Director of Pre-Clinical Translation, Martin McMahon, PhD, have been appointed to prominent national advisory boards within the National Institutes of Health...
